Frontlight ResearchEarly access
Trial site
Azienda Ospedaliera Ordine Mauriziano di Torino
- 8running trials
- 6closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Ovarian cancer2 trials
- Ulcerative colitis2 trials
- Aortic aneurysm1 trial
- Aortic stenosis1 trial
- Chronic spontaneous urticaria1 trial
- Crohn's disease1 trial
- Gastric and oesophageal cancer1 trial
- Liver and biliary tract cancer1 trial
- Lupus (SLE)1 trial
- Myelodysplastic syndromes1 trial
- Myeloproliferative neoplasms1 trial
- Obesity1 trial
- Phase
- Phase 35 trials
- Phase 23 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting5 trials
- Completed4 trials
- Recruiting2 trials
- Terminated2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- AbbVie1 trial
- Amgen1 trial
- ARCAGY/ GINECO GROUP1 trial
- Ascentage Pharma Group Inc.1 trial
- Bristol-Myers Squibb1 trial
- and 9 more
Running trials
Enrolling by invitation
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis
Recruiting
Active, not recruiting
Acute Normovolemic Hemodilution in High Risk Cardiac Surgery Patients.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic spontaneous urticaria1 recruiting
- Lupus (SLE)1 recruiting
- Myelodysplastic syndromes1 recruiting
Closed trials
Terminated
Completed
Terminated
Completed
Completed
Completed
ANCHOR (Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System Global Registry)
Site data: ClinicalTrials.govUpdated 17 Nov 2026